Breaking News Instant updates and real-time market news.

AFL

Aflac

$81.24

0.14 (0.17%)

16:21
08/08/17
08/08
16:21
08/08/17
16:21

Aflac board increases shares authorized for repurchase

Aflac's board of directors has authorized the purchase of up to 40M shares of its common stock. This authorization is in addition to the 15.6M shares that remained under a previous authorization as of June 30, 2017, bringing the total number of shares available for purchase to approximately 55.6M. The company anticipates that the repurchase of shares will be conducted from time to time in open market or negotiated transactions, depending on market conditions.

AFL Aflac
$81.24

0.14 (0.17%)

04/06/17
04/06/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Aflac (AFL) upgraded to Neutral from Underperform at BofA/Merrill with analyst Seth Weiss saying Aflac has underperformed the group over the past year while improving its rate of cash flow generation to over 80% of operating earnings in 2014-2016 from 25% of operating earnings in 2011-2013 and has $2.4B of excess capital capacity. 2. Jazz Pharmaceuticals (JAZZ) upgraded to Buy from Neutral at Janney Capital with analyst Ken Trbovich saying the company's settlement with Hikma over Xyrem eliminates a major overhang. While the deal allows Hikma to sell an authorized generic in 2023, about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch and provides Jazz with a "meaningful royalty" on sales, Trbovich noted. 3. PacWest Bancorp (PACW) upgraded to Strong Buy from Outperform at Raymond James with analyst David Long citing the recent pullback in shares, the encouraging investor meeting last month, and increased investor interest in deposit franchises. 4. Abiomed (ABMD) upgraded to Overweight from Neutral at Piper Jaffray with analyst Matt O'Brien saying the company's premium valuation is warranted give its "strong revenue growth outlook, non-existent competition, and considerable earnings power." 5. Marvell (MRVL) assumed with a Buy from Neutral at MKM Partners. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/17
RAJA
04/18/17
UPGRADE
Target $80
RAJA
Outperform
Aflac upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Gregory Peters upgraded Aflac to Outperform with an $80 price target due to valuation ahead of what he sees to be an analyst upgrade cycle in 2H 2017 as investors shift focus to valuation and fundaments from restructuring/reporting changes that have no impact on core operations.
04/18/17
04/18/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Outperform from Market Perform at Bernstein with analyst Sara Senatore saying the company has multiple positive catalysts in its U.s. market, including "a return of food inflation," better value, "more menu innovation," and increased use pf technology. The analyst says that the company is doing well in Japan, while it should benefit from "strong macro trends in Europe." 2. Fastenal (FAST) upgraded to Buy from Hold at Argus with analyst John Eade saying the 10% share correction following first quarter results provides a buying opportunity. 3. Aflac (AFL) upgraded to Outperform from Market Perform at Raymond James with analyst Gregory Peters citing valuation ahead of what he sees to be an analyst upgrade cycle in the second half of 2017 as investors shift focus to valuation and fundamentals from restructuring/reporting changes that have no impact on core operations. 4. Core-Mark (CORE) upgraded to Strong Buy from Outperform at Raymond James with analyst Benjamin Brownlow citing last week's investor meetings with management. The analyst's confidence level in the company's fundamental growth outlook remains high and does not believe the competitive outlook for independents/smaller chain accounts has intensified. 5. Check Point (CHKP) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Keith Weiss saying his recent reseller survey indicates Check Point is maintaining its base, while new subscriptions add to revenue growth. Weiss said margins remain under pressure but stability reduces risk to consensus expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/09/17
JPMS
06/09/17
NO CHANGE
JPMS
Overweight
Aflac president resignation a surprise, says JPMorgan
JPMorgan analyst Jimmy Bhullar views the resignation of Paul Amos II, President of Aflac and son of CEO Dan Amos, as a surprise. Paul Amos was widely regarded as the leading candidate to succeed Dan Amos as CEO, Bhullar tells investors in a research note. The analyst also finds it "odd" that Amos II is receiving a $3.4M payment as part of the resignation, which he notes equates to 30 months of base salary and an annual incentive award for fiscal 2017. Bhullar, however, does not anticipate a major near-term disruption in Aflac's operations or a change in strategy, despite speculation of a separation of the Japan and U.S. divisions. He also now believes CEO Amos is unlikely to retire in the near term, which the analyst views as a positive. Bhullar has an Overweight rating on Aflac and says the stock remains his top pick for the life insurance sector.

TODAY'S FREE FLY STORIES

EVH

Evolent Health

$23.30

0.05 (0.22%)

16:52
06/18/18
06/18
16:52
06/18/18
16:52
Recommendations
Evolent Health analyst commentary  »

Evolent Health Deaconess…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYTM

Rhythm Pharmaceuticals

$28.81

-3.8 (-11.65%)

16:50
06/18/18
06/18
16:50
06/18/18
16:50
Syndicate
Breaking Syndicate news story on Rhythm Pharmaceuticals »

Rhythm Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

CC

Chemours

$48.62

-0.84 (-1.70%)

16:47
06/18/18
06/18
16:47
06/18/18
16:47
Hot Stocks
Chemours announces global price increase of up to 15% for all grades of Vazo »

Chemours announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACAD

Acadia

$15.82

0.05 (0.32%)

16:45
06/18/18
06/18
16:45
06/18/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Acadia »

Point72 Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

TAX

Liberty Tax

$8.40

-0.4 (-4.55%)

16:40
06/18/18
06/18
16:40
06/18/18
16:40
Hot Stocks
Liberty Tax receives noncompliance letter from Nasdaq »

Liberty Tax announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNK

Cinemark

$36.17

0.37 (1.03%)

, AMC

AMC Entertainment

$16.00

0.4 (2.56%)

16:38
06/18/18
06/18
16:38
06/18/18
16:38
Hot Stocks
Cinemark and Cineworld acquire remaining stake in NationalCineMedia for $156.8M »

Cineworld Group and…

CNK

Cinemark

$36.17

0.37 (1.03%)

AMC

AMC Entertainment

$16.00

0.4 (2.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLX

Deluxe

$68.36

0.59 (0.87%)

16:38
06/18/18
06/18
16:38
06/18/18
16:38
Earnings
Deluxe backs FY18 adjusted EPS view $5.60-$5.80, consensus $5.71 »

Cuts FY18 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLX

Deluxe

$68.36

0.59 (0.87%)

16:37
06/18/18
06/18
16:37
06/18/18
16:37
Earnings
Deluxe backs Q2 adjusted EPS view $1.29-$1.35, consensus $1.31 »

Cuts Q2 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLX

Deluxe

$68.36

0.59 (0.87%)

16:36
06/18/18
06/18
16:36
06/18/18
16:36
Hot Stocks
Deluxe enters pact to buy treasury management business »

Deluxe Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBSV

ObsEva

$17.21

2.68 (18.44%)

16:35
06/18/18
06/18
16:35
06/18/18
16:35
Syndicate
ObsEva files to sell 4.75M shares of common stock »

J.P. Morgan Securities,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

TAX

Liberty Tax

$8.40

-0.4 (-4.55%)

16:35
06/18/18
06/18
16:35
06/18/18
16:35
Hot Stocks
Liberty Tax names Michael Piper CFO »

Liberty Tax announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLGL

Sol-Gel Technologies

$8.50

(0.00%)

16:35
06/18/18
06/18
16:35
06/18/18
16:35
Hot Stocks
Sol-Gel Technologies initiates phase 3 program for Papulopustular Rosacea »

Sol-Gel Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

OMP

Oasis Midstream Partners

$17.59

0.3 (1.74%)

16:33
06/18/18
06/18
16:33
06/18/18
16:33
Hot Stocks
Oasis Midstream Partners signs multiple 3rd party agreements in Williston Basin »

Oasis Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

CL

Colgate-Palmolive

$63.30

-1.43 (-2.21%)

16:32
06/18/18
06/18
16:32
06/18/18
16:32
Hot Stocks
Colgate-Palmolive announces $5B share repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

R

Ryder

$73.69

0.49 (0.67%)

16:31
06/18/18
06/18
16:31
06/18/18
16:31
Hot Stocks
Ryder acquires Metro Truck & Tractor Leasing, terms not stated »

Ryder System announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CL

Colgate-Palmolive

$63.30

-1.43 (-2.21%)

16:30
06/18/18
06/18
16:30
06/18/18
16:30
Hot Stocks
Breaking Hot Stocks news story on Colgate-Palmolive »

Colgate-Palmolive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/18/18
06/18
16:30
06/18/18
16:30
Options
Preliminary option volume of 17.3M today »

Preliminary option volume…

KKR

KKR

$24.00

0.085 (0.36%)

, ATCEY

Altice

$0.00

(0.00%)

16:28
06/18/18
06/18
16:28
06/18/18
16:28
Periodicals
KKR near deal to acquire stake in Altice's telecom towers unit, Reuters says »

KKR (KKR) is near a deal…

KKR

KKR

$24.00

0.085 (0.36%)

ATCEY

Altice

$0.00

(0.00%)

BX

Blackstone

$33.03

-0.23 (-0.69%)

AZSEY

Allianz

$0.00

(0.00%)

AXAHY

AXA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OLLI

Ollie's Bargain Outlet

$75.85

0.75 (1.00%)

16:27
06/18/18
06/18
16:27
06/18/18
16:27
Initiation
Ollie's Bargain Outlet initiated  »

Ollie's Bargain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$32.16

-1.24 (-3.71%)

16:27
06/18/18
06/18
16:27
06/18/18
16:27
Syndicate
PagSeguro Digital files to sell 33M shares of Class A common stock »

11,550,000 Class A common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRBK

Green Brick

$12.15

-0.15 (-1.22%)

16:24
06/18/18
06/18
16:24
06/18/18
16:24
Syndicate
Green Brick files to sell 10.7M shares of common stock »

The company is selling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHCI

Comstock Holding

$3.38

-0.05 (-1.46%)

16:23
06/18/18
06/18
16:23
06/18/18
16:23
Hot Stocks
Comstock Holding names Christopher Guthrie new CFO »

Comstock Holding Companie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFIV

F5 Networks

$181.37

-1.27 (-0.70%)

16:20
06/18/18
06/18
16:20
06/18/18
16:20
Downgrade
F5 Networks rating change  »

F5 Networks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

JD

JD.com

$43.75

0.12 (0.28%)

, GOOG

Alphabet

$1,173.63

21.68 (1.88%)

16:20
06/18/18
06/18
16:20
06/18/18
16:20
General news
On The Fly: Top stock stories for Monday »

Stocks began the week in…

JD

JD.com

$43.75

0.12 (0.28%)

GOOG

Alphabet

$1,173.63

21.68 (1.88%)

GOOGL

Alphabet Class A

$1,183.98

24.95 (2.15%)

SQ

Square

$66.19

1.635 (2.53%)

RCII

Rent-A-Center

$14.68

2.655 (22.08%)

WPC

W.P. Carey

$65.73

-1.32 (-1.97%)

ARWR

Arrowhead

$13.72

2.65 (23.94%)

CBPO

China Biologic

$99.29

17.39 (21.23%)

CBIO

Catalyst Biosciences

$9.07

-16.26 (-64.19%)

ZIOP

Ziopharm

$3.51

-0.805 (-18.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 18

    Jun

  • 18

    Jun

  • 20

    Jun

  • 28

    Oct

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
06/18/18
06/18
16:20
06/18/18
16:20
Options
Closing CBOE SPX and VIX Index summary for June 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.